In part one of the three-part series on writing a strong commercialization plan, NCI SBIR Program Director William Bozza invites NCI SBIR-funded biotech innovators, Sid Selvaraj, co-founder and CEO of Arima Genomics, and Manijeh Goldberg, president, founder, and CEO of Privo Technologies, to share advice for aspiring phase II SBIR/STTR applicants: https://sbir.cancer.gov/small-business-funding/grants/bridge-award SBIR DEVELOPMENT CENTER SBIR Innovation Lab Podcast: https://sbir.cancer.gov/about/innovation-lab-podcast SBIR Development Center: https://sbir.cancer.gov/ LEARN MORE FROM THE NATIONAL CANCER INSTITUTE Online: https://www.cancer.gov By Phone: 1-800-4-CANCER (1-800-422-6237) U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute

Ver todos los episodios